메뉴 건너뛰기




Volumn 13, Issue 12, 2012, Pages 6485-6489

Requests for tumor marker tests in turkey without indications and frequency of elevation in benign conditions

Author keywords

AFP; Benign disease; CA 125; CA 15 3; CA 19 9; CEA; Turkey

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MUCIN 1; TUMOR ANTIGEN; TUMOR MARKER;

EID: 84877016170     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6485     Document Type: Article
Times cited : (6)

References (40)
  • 1
    • 79960671871 scopus 로고    scopus 로고
    • Clinical application of tumour markers: a review
    • Amayo AA, Kuria JG (2009). Clinical application of tumour markers: a review. East Afr Med J, 86, 76-83.
    • (2009) East Afr Med J , vol.86 , pp. 76-83
    • Amayo, A.A.1    Kuria, J.G.2
  • 2
    • 0019427959 scopus 로고
    • Elevated levels of circulating carcinoembryonic antigen in hypothyroidism
    • Amino N, Kuro R, Yabu Y, et al (1981). Elevated levels of circulating carcinoembryonic antigen in hypothyroidism. J Clin Endocrinol Metab, 52, 457-62.
    • (1981) J Clin Endocrinol Metab , vol.52 , pp. 457-462
    • Amino, N.1    Kuro, R.2    Yabu, Y.3
  • 3
    • 80053318958 scopus 로고    scopus 로고
    • Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review
    • Ballehaninna UK, Chamberlain RS (2011). Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review. Indian J Surg Oncol, 2, 88-100.
    • (2011) Indian J Surg Oncol , vol.2 , pp. 88-100
    • Ballehaninna, U.K.1    Chamberlain, R.S.2
  • 5
    • 0034075529 scopus 로고    scopus 로고
    • Tumor marker measurements in the diagnosis and monitoring of breast cancer
    • Cheung K, Graves CR, Robertson JF (2000). Tumor marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev, 26, 91-102.
    • (2000) Cancer Treat Rev , vol.26 , pp. 91-102
    • Cheung, K.1    Graves, C.R.2    Robertson, J.F.3
  • 6
    • 34848829608 scopus 로고    scopus 로고
    • Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters
    • Christoforidis A, Lefkou E, Vlachaki E, et al (2007). Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters. Ann Hematol, 86, 837-41.
    • (2007) Ann Hematol , vol.86 , pp. 837-841
    • Christoforidis, A.1    Lefkou, E.2    Vlachaki, E.3
  • 7
    • 0026683985 scopus 로고
    • Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation
    • Collazos J, Genolla J, Ruibal A (1992). Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation. Int J Biol Markers, 7, 97-102.
    • (1992) Int J Biol Markers , vol.7 , pp. 97-102
    • Collazos, J.1    Genolla, J.2    Ruibal, A.3
  • 8
    • 33947173790 scopus 로고    scopus 로고
    • Serum CA-125 is a good predictor of benign disease in patients with postmenopausal ovarian cysts
    • Dikensoy E, Balat O, Ugur MG, Ozkur A, Erkilic S (2007). Serum CA-125 is a good predictor of benign disease in patients with postmenopausal ovarian cysts. Eur J Gynaecol Oncol, 28, 45-7.
    • (2007) Eur J Gynaecol Oncol , vol.28 , pp. 45-47
    • Dikensoy, E.1    Balat, O.2    Ugur, M.G.3    Ozkur, A.4    Erkilic, S.5
  • 9
    • 79960206891 scopus 로고    scopus 로고
    • Relationship of CA 19-9 with choledocholithiasis and cholangitis
    • Dogan UB, Gumurdulu Y, Golge N, Kara B (2011). Relationship of CA 19-9 with choledocholithiasis and cholangitis. Turk J Gastroenterol, 22, 171-7.
    • (2011) Turk J Gastroenterol , vol.22 , pp. 171-177
    • Dogan, U.B.1    Gumurdulu, Y.2    Golge, N.3    Kara, B.4
  • 10
    • 0034968363 scopus 로고    scopus 로고
    • Clinical uses of tumor markers: a clinical review
    • Duffy MJ (2001). Clinical uses of tumor markers: a clinical review. Crit Rev Clin lab Sci, 38, 225-62.
    • (2001) Crit Rev Clin lab Sci , vol.38 , pp. 225-262
    • Duffy, M.J.1
  • 11
    • 80055080310 scopus 로고    scopus 로고
    • Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases
    • Escudero JM, Auge JM, Filella X, et al (2011). Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem, 57, 1534-44.
    • (2011) Clin Chem , vol.57 , pp. 1534-1544
    • Escudero, J.M.1    Auge, J.M.2    Filella, X.3
  • 13
    • 33947668471 scopus 로고    scopus 로고
    • Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
    • Goonetilleke KS, Siriwardena AK (2007). Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol, 33, 266-70.
    • (2007) Eur J Surg Oncol , vol.33 , pp. 266-270
    • Goonetilleke, K.S.1    Siriwardena, A.K.2
  • 14
    • 0036789588 scopus 로고    scopus 로고
    • Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis
    • Harada T, Kubota T, Aso T (2002). Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril, 78, 733-9.
    • (2002) Fertil Steril , vol.78 , pp. 733-739
    • Harada, T.1    Kubota, T.2    Aso, T.3
  • 15
    • 0038522808 scopus 로고    scopus 로고
    • A new cause for CA19.9 elevation: heavy tea consumption
    • Howaizi M, Abboura M, Krespine C, et al (2003). A new cause for CA19.9 elevation: heavy tea consumption. Gut, 52, 913-4.
    • (2003) Gut , vol.52 , pp. 913-914
    • Howaizi, M.1    Abboura, M.2    Krespine, C.3
  • 16
    • 34547765277 scopus 로고    scopus 로고
    • Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression
    • Kannagi R (2007). Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J, 30, 189-209.
    • (2007) Chang Gung Med J , vol.30 , pp. 189-209
    • Kannagi, R.1
  • 18
    • 84866266908 scopus 로고    scopus 로고
    • Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT
    • Kobeisy MA, Morsy KH, Galal M, et al (2012). Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT. Arab J Gastroenterol, 13, 49-53.
    • (2012) Arab J Gastroenterol , vol.13 , pp. 49-53
    • Kobeisy, M.A.1    Morsy, K.H.2    Galal, M.3
  • 19
    • 0015359515 scopus 로고
    • The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue
    • Krupey J, Wilson T, Freedman SO, Gold P, (1972). The preparation of purified carcinoembryonic antigen of the human digestive system from large quantities of tumor tissue. Immunochemistry, 9, 617-22.
    • (1972) Immunochemistry , vol.9 , pp. 617-622
    • Krupey, J.1    Wilson, T.2    Freedman, S.O.3    Gold, P.4
  • 20
    • 70350509564 scopus 로고    scopus 로고
    • Carcinoembryonic antigen screening: how far should we go?
    • Lim YK, Kam MH, Eu KW, (2009). Carcinoembryonic antigen screening: how far should we go?. Singapore Med J, 50, 862-5.
    • (2009) Singapore Med J , vol.50 , pp. 862-865
    • Lim, Y.K.1    Kam, M.H.2    Eu, K.W.3
  • 21
    • 33846595479 scopus 로고    scopus 로고
    • ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
    • Locker GY, Hamilton S, Harris J, et al (2006). ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24, 5313-27.
    • (2006) J Clin Oncol , vol.24 , pp. 5313-5327
    • Locker, G.Y.1    Hamilton, S.2    Harris, J.3
  • 22
    • 77957892168 scopus 로고    scopus 로고
    • Serum markers of hepatocellular carcinoma
    • Malaguarnera G, Giordano M, Paladina I, et al (2010). Serum markers of hepatocellular carcinoma. Dig Dis Sci, 55, 2744-55.
    • (2010) Dig Dis Sci , vol.55 , pp. 2744-2755
    • Malaguarnera, G.1    Giordano, M.2    Paladina, I.3
  • 23
    • 0023687299 scopus 로고
    • Serum levels of CA-50, CA-19-9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung
    • Marechal F, Berthiot G, Deltour G (1988). Serum levels of CA-50, CA-19-9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res, 8, 677-80.
    • (1988) Anticancer Res , vol.8 , pp. 677-680
    • Marechal, F.1    Berthiot, G.2    Deltour, G.3
  • 24
    • 1842633556 scopus 로고    scopus 로고
    • The clinical significance of elevated levels of serum CA 19-9
    • Pavai S, Yap SF (2003). The clinical significance of elevated levels of serum CA 19-9. Med J Malaysia, 58, 667-72.
    • (2003) Med J Malaysia , vol.58 , pp. 667-672
    • Pavai, S.1    Yap, S.F.2
  • 26
    • 0347518973 scopus 로고    scopus 로고
    • The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion
    • Ryu JS, Lee HJ, Cho JH, Han HS, Lee HL (2003). The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion. Respirology, 8, 487-91.
    • (2003) Respirology , vol.8 , pp. 487-491
    • Ryu, J.S.1    Lee, H.J.2    Cho, J.H.3    Han, H.S.4    Lee, H.L.5
  • 27
    • 46349110598 scopus 로고    scopus 로고
    • Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers
    • Sajid KM, Chaouachi K, Mahmood R (2008). Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers. Harm Reduct J, 5, 19.
    • (2008) Harm Reduct J , vol.5 , pp. 19
    • Sajid, K.M.1    Chaouachi, K.2    Mahmood, R.3
  • 28
    • 79751510053 scopus 로고    scopus 로고
    • Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
    • Serefhanoglu S, Buyukasik Y, Emmungil H, et al (2010). Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia. Int J Med Sci, 8, 30-8.
    • (2010) Int J Med Sci , vol.8 , pp. 30-38
    • Serefhanoglu, S.1    Buyukasik, Y.2    Emmungil, H.3
  • 29
    • 0024445385 scopus 로고
    • CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia
    • Shiota Y, Furuya K, Kitade M, Ueda N, (1989). CEA and CA19-9 in BALF from patients with idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi, 27, 887-93.
    • (1989) Nihon Kyobu Shikkan Gakkai Zasshi , vol.27 , pp. 887-893
    • Shiota, Y.1    Furuya, K.2    Kitade, M.3    Ueda, N.4
  • 30
    • 13844311017 scopus 로고    scopus 로고
    • Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency
    • Symeonidis A, Kouraklis-Symeonidis A, Apostolopoulos D, et al (2004). Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency. Oncology, 67, 359-67.
    • (2004) Oncology , vol.67 , pp. 359-367
    • Symeonidis, A.1    Kouraklis-Symeonidis, A.2    Apostolopoulos, D.3
  • 31
    • 33646703759 scopus 로고    scopus 로고
    • Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia
    • Symeonidis A, Kouraklis-Symeonidis A, Constantinidou I, et al (2006). Increased CA-15.3 levels in the serum of patients with homozygous beta-thalassaemia and sickle cell/beta-thalassaemia. Br J Haematol, 133, 692-4.
    • (2006) Br J Haematol , vol.133 , pp. 692-694
    • Symeonidis, A.1    Kouraklis-Symeonidis, A.2    Constantinidou, I.3
  • 32
    • 84863916455 scopus 로고    scopus 로고
    • CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results
    • Szubert M, Suzin J, Wierzbowski T, Kowalczyk-Amico K (2012). CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results. Arch Med Sci, 8, 504-8.
    • (2012) Arch Med Sci , vol.8 , pp. 504-508
    • Szubert, M.1    Suzin, J.2    Wierzbowski, T.3    Kowalczyk-Amico, K.4
  • 33
    • 81055156135 scopus 로고    scopus 로고
    • CA-125 and heart failure: reiteration and reappraisal
    • Topatan B, Basaran A, (2011). CA-125 and heart failure: reiteration and reappraisal. Int J Cardiol, 153, 76-8.
    • (2011) Int J Cardiol , vol.153 , pp. 76-78
    • Topatan, B.1    Basaran, A.2
  • 35
    • 0036969867 scopus 로고    scopus 로고
    • Increased serum levels of the tumor marker CA 15-3 on patients with pernicious (Biermer) anemia
    • Triantafillidis JK, Cheracakis P, Konstantellou E, Hyphantis T, (2002). Increased serum levels of the tumor marker CA 15-3 on patients with pernicious (Biermer) anemia. Oncology, 63, 306-7.
    • (2002) Oncology , vol.63 , pp. 306-307
    • Triantafillidis, J.K.1    Cheracakis, P.2    Konstantellou, E.3    Hyphantis, T.4
  • 36
    • 34848885205 scopus 로고    scopus 로고
    • Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion
    • Wagner IC, Guimaraes MJ, da Silva LK, de Melo FM, Muniz MT (2007). Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion. J Bras Pneumol, 33, 185-91.
    • (2007) J Bras Pneumol , vol.33 , pp. 185-191
    • Wagner, I.C.1    Guimaraes, M.J.2    da Silva, L.K.3    de Melo, F.M.4    Muniz, M.T.5
  • 37
    • 0021086375 scopus 로고
    • Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure
    • Witherspoon LR, Shuler SE, Alyea K, Husserl FE (1983). Carcinoembryonic antigen: assay following heat compared with perchloric acid extraction in patients with colon cancer, non-neoplastic gastrointestinal diseases, or chronic renal failure. J Nucl Med, 24, 916-21.
    • (1983) J Nucl Med , vol.24 , pp. 916-921
    • Witherspoon, L.R.1    Shuler, S.E.2    Alyea, K.3    Husserl, F.E.4
  • 38
  • 39
    • 84863712467 scopus 로고    scopus 로고
    • Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients
    • Yu H, Li R, Zhang L, et al (2012). Serum CA19-9 level associated with metabolic control and pancreatic beta cell function in diabetic patients. Exp Diabetes Res, 2012, 745189.
    • (2012) Exp Diabetes Res , vol.2012 , pp. 745189
    • Yu, H.1    Li, R.2    Zhang, L.3
  • 40
    • 84855283454 scopus 로고    scopus 로고
    • Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers
    • Yue T, Maupin KA, Fallon B, et al (2011). Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PLoS One, 6, 29180
    • (2011) PLoS One , vol.6 , pp. 29180
    • Yue, T.1    Maupin, K.A.2    Fallon, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.